Clinical Trials Browser

Phase 2/3 × OTHER × Gefitinib × Clear all

NCT02326285 2018-01-23

NeoIntercal

Phase 2/3 Terminated

Carcinoma, Non-Small-Cell Lung

NCT02387086 2015-03-12

Gefitinib Combined With Thalidomide to Treat NSCLC

Phase 2/3 Unknown

NSCLC

NCT02338011 2015-01-26

EGFR

Phase 2/3 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung